Standardization of the method of multi-target single-nucleotide elongation for molecular genetic study of cytological material in thyroid neoplasm
- Authors: Fedorova P.A1, Nazarov V.D1, Musaelyan A.A1, Lapin S.V1, Boriskova M.E1, Farafonova U.V1, Emanuel V.L1
-
Affiliations:
- Pavlov First Saint-Petersburg State Medical University
- Issue: Vol 18, No 6 (2020)
- Pages: 31-37
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113344
- DOI: https://doi.org/10.29296/24999490-2020-06-05
- ID: 113344
Cite item
Abstract
Full Text
About the authors
P. A Fedorova
Pavlov First Saint-Petersburg State Medical University
Email: fedorova97@gmail.com
Researcher of Laboratory for Diagnosis of Autoimmune Diseases Lva Tolstogo str., 6-8, Saint Petersburg, 197022, Russian Federation
V. D Nazarov
Pavlov First Saint-Petersburg State Medical University
Email: nazarov19932@mail.ru
Junior Researcher of Laboratory for Diagnosis of Autoimmune Diseases of Pavlov First Saint Petersburg State Medical University, Russian Federation, PhD. Lva Tolstogo str., 6-8, Saint Petersburg, 197022, Russian Federation
A. A Musaelyan
Pavlov First Saint-Petersburg State Medical University
Email: a.musaelyan8@gmail.com
a 1st year resident of Pavlov First Saint Petersburg State Medical University, Russian Federation, Researcher of Laboratory for Diagnosis of Autoimmune Diseases Lva Tolstogo str., 6-8, Saint Petersburg, 197022, Russian Federation
S. V Lapin
Pavlov First Saint-Petersburg State Medical University
Email: svlapin@mail.ru
Head of Laboratory for Diagnosis of Autoimmune Diseases of Pavlov First Saint Petersburg State Medical University, Russian Federation, PhD. Lva Tolstogo str., 6-8, Saint Petersburg, 197022, Russian Federation
M. E Boriskova
Pavlov First Saint-Petersburg State Medical University
Email: boriskovam@gmail.com
Docent, Head of Division of Endocrine Surgery of Pavlov First Saint Petersburg State Medical University, Russian Federation, PhD. Lva Tolstogo str., 6-8, Saint Petersburg, 197022, Russian Federation
U. V Farafonova
Pavlov First Saint-Petersburg State Medical University
Email: medici@yandex.ru
Surgeon of Division of Endocrine Surgery of Pavlov First Saint Petersburg State Medical University, Russian Federation, PhD. Lva Tolstogo str., 6-8, Saint Petersburg, 197022, Russian Federation
V. L Emanuel
Pavlov First Saint-Petersburg State Medical University
Email: vladimirem1@gmail.com
Professor, Head of Department of Clinical Laboratory Diagnostics with Molecular Medicine Course of Pavlov First Saint Petersburg State Medical University, Russian Federation, PhD Lva Tolstogo str., 6-8, Saint Petersburg, 197022, Russian Federation
References
- Hay I.D., Thompson G.B., Grant C.S., Bergstralh E.J., Dvorak C.E., Gorman C.A. et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (19401999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J. Surg. 2002; 26 (8): 879-85. https://doi.org/10.1007/s00268-002-6612-1
- Saiselet M., Floor S., Tarabichi M., Dom G., H brant A., van Staveren W.C.G. et al. Thyroid cancer cell lines: An overview. Front Endocrinol (Lausanne). 2012; 3: 1-9. https://doi.org/10.3389/fendo.2012.00133
- Haugen B.R., Alexander E.K., Bible K.C., Doherty G.M., Mandel S.J., Nikiforov YE. et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid (Internet). 2016;1-133. https://doi.org/10.1089/ thy.2015.0020
- Xing M. Clinical utility of RAS mutations in thyroid cancer: A blurred picture now emerging clearer. BMC Medicine. 2016. https://doi.org/10.1089/thy2015.0020
- Fernandez-Ramirez F., Hurtado-Lopez L.M., Lopez M.A., Martinez-Penafiel E., Herrera-Gonzalez N.E., Kameyama L. et al. BRAF 1799T>A Mutation Frequency in Mexican Mestizo Patients with Papillary Thyroid Cancer. Biomed Res Int. 2018; 2018. https:// doi.org/10.1155/2018/2582179
- Ferrari S.M., Fallahi P., Ruffilli I., Elia G., Ragusa F, Paparo S.R. et al. Molecular testing in the diagnosis of differentiated thyroid carcinomas. Gland Surg. 2018;19-29. https://doi.org/10.21037/ gs.2017.11.07
- Kim W.W., Ha T.K., Bae S.K. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis. J. Otolaryngol - Head Neck Surg. 2018; 47 (1): 1-6. https://doi.org/10.1186/ s40463-017-0247-6
- Абросимов А.Ю. Инкапсулированные фолликулярные опухоли щитовидной железы неопределенного злокачественного потенциала в новой международной гистологической классификации. Клиническая и экспериментальная тиреоидология, 2018; 13 (4): 9-15. https:// doi.org/10.14341/ket9481
- Мусаелян А.А., Чистяков И.В., Назаров В.Д., Лапин С.В., Согоян М.В., Хальчицкий С.Е., Эмануэль В.Л., Лобачевская Т.В. Акопов А.Л. Оптимизация метода мультитаргетной однонуклеотидной элонгации для определния соматических мутаций при злокачественных ноовобразованиях. Молекулярная медицина. 2019; 2 (17). https://doi.org/10.29296/24999490-2019-02-06
- Под ред. Каприна А.Д., Старинского В.В., Петровой Г.В. Злокачественные новообразования в россии в 2017 году (заболеваемость и смертность). 2018
- Xie H., Wei B., Shen H., Gao Y, Wang L., Liu H. BRAF mutation in papillary thyroid carcinoma (PTC) and its association with clinicopathological features and systemic inflammation response index (SIRI). Am. J. Transl Res. 2018; 10 (8): 2726-36.
- Nikiforov Y.E. Role of Molecular Markers in Thyroid Nodule Management: Then and Now. Endocr Pract (Internet). 2017; (aop): EP171805.RA. https://doi.org/10.4158/ EP171805.RA
- Strickland K.C., Eszlinger M., Paschke R., Angell T.E., Alexander E.K., Marqusee E. et al. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Endocr Pathol. 2018; 29 (1): 68-74. https://doi.org/10.1007/s12022-018-9515-x